On testing simultaneously non-inferiority in two multiple primary endpoints and superiority in at least one of them
From MaRDI portal
Publication:5122886
DOI10.1002/BIMJ.200510289zbMATH Open1442.62591OpenAlexW2022685057WikidataQ51924773 ScholiaQ51924773MaRDI QIDQ5122886FDOQ5122886
Authors: Joachim Röhmel, Christoph Gerlinger, Norbert Benda, Jürgen Läuter 
Publication date: 24 September 2020
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/bimj.200510289
Recommendations
- Note on simultaneous inferences about non-inferiority and superiority for a primary and a secondary endpoint
- Superiority inferences on individual endpoints following noninferiority testing in clinical trials
- Assessing additional benefit in noninferiority trials
- Sequential tests for noninferiority and superiority
- A superiority-equivalence approach to one-sided tests on multiple endpoints in clinical trials
Cited In (8)
- Testing for efficacy in primary and secondary endpoints by partitioning decision paths
- Consistency-adjusted alpha allocation methods for a time-to-event analysis of composite endpoints
- Assessing additional benefit in noninferiority trials
- Sequential tests for noninferiority and superiority
- Statistical tests based on new composite hypotheses in clinical trials reflecting the relative clinical importance of multiple endpoints quantitatively
- Note on simultaneous inferences about non-inferiority and superiority for a primary and a secondary endpoint
- A superiority-equivalence approach to one-sided tests on multiple endpoints in clinical trials
- Superiority inferences on individual endpoints following noninferiority testing in clinical trials
This page was built for publication: On testing simultaneously non-inferiority in two multiple primary endpoints and superiority in at least one of them
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5122886)
